Cal-Maine
CALM
$79.57
+4.74%
Cal-Maine Foods Inc is the largest producer and marketer of shell eggs in the United States, operating within the Agricultural Farm Products sector of Consumer Defensive. The company is a dominant market leader, distinguished by its vertically integrated operations and a diversified portfolio that includes conventional, cage-free, organic, and nutritionally enhanced eggs under brands like Egg-Land's Best and Land O' Lakes. The current investor narrative revolves around the company's strategic use of its immense cash reserves for acquisitions, such as the recent purchase of Creighton Brothers, to expand its footprint, juxtaposed against the cyclical pressures of the egg market which have led to a significant year-over-year revenue decline, creating a debate between its defensive cash-rich balance sheet and exposure to volatile commodity pricing.…
CALM
Cal-Maine
$79.57
Related headlines
CALM 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Cal-Maine's 12-month outlook, with a consensus price target around $103.44 and implied upside of +30.0% versus the current price.
Average Target
$103.44
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$64 - $103
Analyst target range
Insufficient analyst coverage available, with only two analysts providing estimates, which implies limited institutional interest and research focus on this mid-cap, cyclical agricultural stock. The low coverage can lead to higher volatility and less efficient price discovery, as the stock's moves are more driven by commodity price swings and company-specific news rather than a broad analyst consensus, placing a greater onus on investors to conduct their own fundamental due diligence.
Bulls vs Bears: CALM Investment Factors
The investment debate for CALM centers on the tension between its pristine, cash-rich balance sheet and its exposure to severe cyclical pressures in the egg market. The bearish evidence is currently stronger, as reflected in the persistent price decline, margin compression, and high short interest. The single most important factor is the trajectory of egg prices and margins; a stabilization or rebound would validate the bullish thesis of a deeply undervalued market leader, while a further decline would confirm the bearish view of an extended earnings downturn that the high forward P/E is anticipating.
Bullish
- Exceptionally Strong Balance Sheet: The company is debt-free with a D/E ratio of 0 and holds a robust current ratio of 6.38, providing immense financial flexibility. This fortress balance sheet, coupled with $1.17B in TTM free cash flow, enables strategic acquisitions like Creighton Brothers and supports dividends without external financing, offering a significant buffer against cyclical downturns.
- Dominant Market Leader in Defensive Sector: As the largest U.S. shell egg producer, CALM operates in the Consumer Defensive sector, which is inherently less cyclical. Its low beta of 0.265 confirms its low correlation to the broader market, which gained 28.21% while CALM fell 20.57%, indicating it provides a defensive shelter during market volatility.
- Extremely Low Valuation on Trailing Earnings: The stock trades at a trailing P/E of just 3.83x, which is near the low end of its recent historical range (2.17x to 9.73x). This depressed multiple suggests the market has already priced in a severe earnings decline, limiting the potential for further multiple compression and offering a deep-value entry point if the cycle stabilizes.
- Strategic Use of Cash for Growth: Recent news highlights the company is actively deploying its cash hoard for accretive acquisitions, such as Creighton Brothers, to expand its geographic footprint and market share. This inorganic growth strategy can help offset the cyclical revenue decline and position the company for the next upswing.
Bearish
- Severe Cyclical Revenue and Margin Pressure: Revenue declined 19.4% YoY last quarter, and net margin compressed sharply from 21.61% to 13.35% sequentially. This accelerating downturn reflects the inherent volatility of commodity egg prices, and with a forward P/E of 20.73x, the market is bracing for a significant earnings collapse.
- Sustained Technical Downtrend: The stock is down 20.57% over the past year and 14.22% over the past three months, trading near the lower end of its 52-week range. It shows persistent negative relative strength, underperforming the S&P 500 by -48.78% over the past year, indicating strong and sustained selling pressure.
- High Short Interest: A short ratio of 7.99 indicates significant bearish sentiment and a high level of short interest. This creates a technical overhang and potential for further downside pressure if negative fundamentals persist, as short sellers continue to bet against a near-term recovery.
- Limited Analyst Coverage and Visibility: With only two analysts providing estimates, there is limited institutional research and price discovery. This can lead to higher volatility and mispricing, as the stock is more susceptible to swings driven solely by commodity price news rather than deep fundamental analysis.
CALM Technical Analysis
The stock is in a pronounced downtrend, having declined 20.57% over the past year, and is currently trading near the lower end of its 52-week range, approximately 41% above its 52-week low of $71.92 and 41% below its high of $126.40. This positioning near the lows suggests the stock is in a value-seeking zone but remains vulnerable to further selling pressure if fundamental headwinds persist. Recent momentum shows continued weakness, with the stock down 14.22% over the past three months and a slight 0.47% decline over the past month, indicating the longer-term downtrend is decelerating but has not yet reversed. The stock's beta of 0.265 highlights its low volatility and defensive nature, as it has moved significantly less than the broader market, which gained 28.21% over the past year. Key technical levels are clearly defined, with the 52-week low of $71.92 acting as critical support; a sustained breakdown below this level would signal a new leg down, while resistance sits near the $126.40 high, with any meaningful recovery needing to first overcome the recent trading range between $74 and $90.
Beta
0.24
0.24x market volatility
Max Drawdown
-39.2%
Largest decline past year
52-Week Range
$72-$126
Price range past year
Annual Return
-21.6%
Cumulative gain past year
| Period | CALM Return | S&P 500 |
|---|---|---|
| 1m | +3.3% | -1.6% |
| 3m | +1.9% | +11.7% |
| 6m | -3.9% | +6.3% |
| 1y | -21.6% | +22.2% |
| ytd | +1.4% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CALM Fundamental Analysis
Revenue is in a sharp cyclical decline, with the most recent quarterly figure at $769.5 million, representing a 19.4% year-over-year contraction, and this follows a sequential drop from $922.6 million in the prior quarter, indicating accelerating negative momentum. The company remains profitable but under pressure, posting net income of $102.8 million last quarter, which translates to a net margin of 13.35%, a significant compression from the 21.61% margin in the prior quarter, while gross margin also contracted to 26.95% from 33.74%. The balance sheet is exceptionally strong and debt-free, with a debt-to-equity ratio of 0, a robust current ratio of 6.38, and trailing twelve-month free cash flow of $1.17 billion, providing ample liquidity to fund strategic acquisitions and dividends without relying on external financing, which is a critical mitigant against the cyclical revenue downturn.
Quarterly Revenue
$769498000.0B
2025-11
Revenue YoY Growth
-0.19%
YoY Comparison
Gross Margin
+0.26%
Latest Quarter
Free Cash Flow
$1.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CALM Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is exceptionally low at 3.83x, while the forward PE is substantially higher at 20.73x, indicating the market expects a significant earnings decline in the coming year, which aligns with the observed margin compression and revenue drop. Compared to sector averages, data is not available for a direct peer comparison, but the low trailing multiple suggests the market is pricing in a deep cyclical trough. Historically, the stock's own PE ratio has fluctuated wildly, from recent highs above 9.73x in late 2025 to lows near 2.17x in early 2025; the current 3.83x sits near the lower end of this recent band, implying the market's expectations are already depressed, potentially limiting further multiple contraction barring a fundamental catastrophe.
PE
3.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -100x~627x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
2.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are dominated by the extreme cyclicality of the egg market, as evidenced by the 19.4% YoY revenue decline and the sequential net margin compression from 21.61% to 13.35%. While the company is debt-free with a $1.17B free cash flow cushion, its earnings are highly volatile and dependent on commodity pricing, creating significant uncertainty in forecasting future profitability. The primary risk is that the current downturn is not a typical cycle but a structural shift, though the strong balance sheet mitigates solvency concerns.
Market & Competitive Risks stem from its valuation and sector dynamics. The stock trades at a forward P/E of 20.73x, which prices in a severe earnings decline. If this decline materializes but is less severe than feared, the multiple could compress further. The stock's low beta of 0.265 offers defensive characteristics but also means it may not participate in broader market rallies. Competitive risks are moderate given its market leadership, but the industry remains fragmented and subject to pricing pressures from larger retailers and shifts in consumer demand toward cage-free and organic products, which require ongoing capital investment.
The Worst-Case Scenario involves a prolonged and deeper-than-expected trough in egg prices, coupled with rising feed costs, squeezing margins further. This could lead to consecutive quarterly earnings misses, triggering analyst downgrades and a flight of remaining investors. In this adverse scenario, the stock could re-test its 52-week low of $71.92, representing a downside of approximately -3.7% from the current price of $74.72. A more severe bear case, factoring in a re-rating to its historical low P/E near 2.17x on depressed earnings, could imply a downside of -30% to -40% from current levels.